Google+ is open to brands — and might be especially enticing to the healthcare industry. Pharma specialist Mark Senak
questions whether the Google+ will replace utility “some saw as compromised” with Facebook’s updates.
Healthcare
Will Pharma Find a Plus in Google’s Social Network?
Posted on November 10th, 2011 | More Digital & Social Media · Healthcare
A Checkup on Pharma’s Blogging Habits
Despite the opportunities, healthcare companies and the FDA do not appear to be “burning up the blogosphere.” Pharma specialist Mark Senak
reviews several companies’ habits — and the trend that might be forming.Posted on November 3rd, 2011 | More B2B · B2C · Digital & Social Media · Healthcare · Public Affairs
Will New Sunshine Act Have Cloudy Context?
Pharma specialist Mark Senak
examines the Physician Payment Sunshine Act and explains why the new law is “more than a matter of compliance.”Posted on October 25th, 2011 | More Healthcare · Public Affairs
An Inside View on Government-Charity Relationships
In a Third Sector column, digital specialist Dean Russell offers a district councilor’s view on local U.K. healthcare — and how to change the “unnecessary duplication” with government and charities.
Posted on October 10th, 2011 | More Digital & Social Media · Healthcare · Public Affairs
Do New FDA Efforts Go Beyond ‘Window Dressing’?
Do some simple links have big meaning for the FDA’s transparency efforts? Pharma specialist Mark Senak
explains why there has been “progress to change the status quo.”Posted on October 6th, 2011 | More Digital & Social Media · Healthcare · Public Affairs
Targeted Therapies, Targeted Communications Helping Pharma
As treatments become more targeted, some observers suggest pharma communications should move beyond “press releases factories.” The communications specialists in Mexico
provide four strategic targets to avoid an “ineffective and toxic” solution.Posted on October 3rd, 2011 | More Convergent Marketing · Digital & Social Media · Healthcare
The Twitter Influence on Healthcare Advocacy
Regardless of a healthcare company’s social media involvement, e-advocacy appears to be growing quickly. Pharma specialist Mark Senak
explains how organizations can adapt as “fax trees” give way to Twitter.Posted on September 29th, 2011 | More Digital & Social Media · Healthcare · Public Affairs · Third Parties
How FDA Can Compete in the Land of Oz
While the FDA wants to appear professional, some observers suggest a lack of persona could hurt its message. Pharma specialist Mark Senak
weighs in on the agency’s spat with celebrity physician Dr. Oz and explains why it should consider “softening the edges.”Posted on September 19th, 2011 | More Digital & Social Media · Entertainment · Healthcare · Public Affairs
Thoughts on Google’s ThinkHealth
Pharma specialist Mark Senak
talks about Google’s upcoming ThinkHealth 2011, including which session is the “most promising” and what appears to be missing from the event.Posted on September 12th, 2011 | More Digital & Social Media · Healthcare · Mobile · Public Affairs
What the ‘Longevity Phenomenon’ Means to Marketers
Are brands focusing enough on the “aging opportunity”? The communications specialists in Ireland
discuss the demographic and explain why companies shouldn’t look at it “as one big block aged 65 plus.”Posted on September 8th, 2011 | More B2C · Boomers · Healthcare · Research
